Iaffaldano, Laura (2013) A specific immunophenotype and an increased adipogenic potential characterized human amniotic mesenchymal stem cells (hA-MSCs) isolated from obese pregnant women at delivery. [Tesi di dottorato]
Preview |
Text
Iaffaldano_Laura_25.pdf Download (5MB) | Preview |
| Item Type: | Tesi di dottorato |
|---|---|
| Resource language: | English |
| Title: | A specific immunophenotype and an increased adipogenic potential characterized human amniotic mesenchymal stem cells (hA-MSCs) isolated from obese pregnant women at delivery |
| Creators: | Creators Email Iaffaldano, Laura laura.iaffaldano@unina.it |
| Date: | 2 April 2013 |
| Number of Pages: | 107 |
| Institution: | Università degli Studi di Napoli Federico II |
| Department: | Medicina Molecolare e Biotecnologie Mediche |
| Scuola di dottorato: | Medicina molecolare |
| Dottorato: | Genetica e medicina molecolare |
| Ciclo di dottorato: | 25 |
| Coordinatore del Corso di dottorato: | nome email Nitsch, Lucio lucio.nitsch@unina.it |
| Tutor: | nome email Tinto, Nadia nadia.tinto@unina.it |
| Date: | 2 April 2013 |
| Number of Pages: | 107 |
| Keywords: | Obesity, Stem cell, CD13 |
| Settori scientifico-disciplinari del MIUR: | Area 05 - Scienze biologiche > BIO/12 - Biochimica clinica e biologia molecolare clinica |
| Date Deposited: | 12 Apr 2013 12:33 |
| Last Modified: | 22 Jul 2014 08:57 |
| URI: | http://www.fedoa.unina.it/id/eprint/9448 |
| DOI: | 10.6092/UNINA/FEDOA/9448 |
Collection description
Maternal obesity is associated to increased fetal risk of obesity and other metabolic diseases. Human amniotic mesenchymal stem cells (hA-MSC) have not been characterized in obese women. The aim of this study was to isolate and compare hA-MSC immunophenotypes from obese (Ob-) and normal weight control (Co-) women to identify alterations possibly predisposing the foetus to obesity. We enrolled 16 Ob- and 7 Co-women at delivery (mean/SEM pre-pregnancy BMI: 40.3/1.8 kg/m2 and 22.4/1.0 kg/m2, respectively). hA-MSCs were phenotyped by flow cytometry; several maternal and newborn clinical and biochemical parameters were also measured. The expression of membrane antigen CD13 was higher on Ob-hA-MSCs than on Co-hA-MSCs (P=0.0043). Also serum levels of CD13 at delivery were higher in Ob- versus Co-pregnant women and correlated with CD13 antigen expression on Ob-hA-MSCs (r2=0.84, P<0.0001). Adipogenesis induction experiments revealed that Ob-hA-MSCs had a higher adipogenic potential than Co-hA-MSCs as witnessed by higher PPARg and aP2 mRNA levels (P=0.02 and P=0.03, respectively) at post-induction day 14 associated with an increase of CD13 mRNA from baseline to day 4 post-induction (P<0.05). Adipogenesis was similar in the two sets of hA-MSCs after CD13 silencing, whereas it was increased in Co-hA-MSCs after CD13 overexpression. Pretreatment of Co- and Ob-hA-MSCs with IFN-g ng/mL) for 24 h induced upregulation of CD13 expression. In conclusion, antigen CD13, by influencing the adipogenic potential of hA-MSCs could be an in-utero risk factor for obesity. Our data strengthen the hypothesis that high levels of serum and MSC CD13 are obesity markers.
Downloads
Downloads per month over past year
Actions (login required)
 |
View Item |
